ArticleJournal of virology2025
PRRSV GP2a blocks the RLR signaling pathway by targeting RIG-I.
Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The strategy of viruses targeting RIG-I to disrupt the interferon (IFN) system represents an effective mechanism for evading innate immune responses. In this study, we observed that porcine reproductive and respiratory syndrome virus (PRRSV) GP2a inhibited IFN production by targeting RIG-I. Further studies revealed that GP2a blocks the RIG-I-like receptor signaling pathway through two mechanisms: (i) GP2a induces K48-linked ubiquitination of RIG-I by promoting the interaction between RIG-I and RING finger protein 125 (RNF125), resulting in RIG-I degradation, and (ii) GP2a hijacks zinc finger CCHC-type containing 3 (ZCCHC3) to disrupt the formation of the tripartite motif-containing 25 (TRIM25)-RIG-I complex, thereby inhibiting RIG-I K63-linked ubiquitination. This inhibition effectively prevents the activation and expression of RIG-I. In conclusion, our findings demonstrate novel mechanisms by which PRRSV GP2a inhibits IFN production, thereby improving our understanding of PRRSV immune evasion strategies.IMPORTANCEPorcine reproductive and respiratory syndrome is an important viral disease that affects the swine industry worldwide. PRRSV glycoproteins (GPs) play a crucial role in the viral infection process. However, it remains largely unknown about what roles PRRSV GPs play in antagonizing the innate immune response. In this study, we found that GP2a targets RIG-I to inhibit IFN production through a dual-faceted mechanism. GP2a promotes the RNF125-mediated degradation of RIG-I and competitively interacts with ZCCHC3 to impede TRIM25-induced RIG-I activation. This research contributes to a deeper understanding of the immune escape mechanisms employed by PRRSV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.